Released on = April 30, 2007, 9:33 pm

Press Release Author = Bharat Book Bureau

Industry = Pharmaceuticals

Press Release Summary = The news has been full of industry developments and
financial investments in stem cell research in recent weeks. Your company must be
aware of the latest developments immediately.

Press Release Body = The news has been full of industry developments and financial
investments in stem cell research in recent weeks. Your company must be aware of the
latest developments immediately.

Researchers Find New Source For Stem Cells That Could End Debate
Brain stem cells against cancer?
\'Bio-ink\' Printer Transforms Stem Cells
US delegation divided over stem cells
Stem cells are without doubt the most controversial area of science at the moment.
The world markets have latched onto the potential offered by stem cells to modern
medicine and, as a result, the research is in the public eye on an almost daily
basis. Are you fully informed of the market potential of stem cell work? Do you know
which companies and research organisations you must work with now? This report tells
you.

So what is all the controversy about? And what products are we likely to see, in
what areas and when, if stem cell work continues at pace?

The potential lies in that given the right circumstances, embryonic stem cells could
be used to create new tissues and organs for patients whose tissues or organs have
been destroyed, damaged, diseased or have simply aged. For example, for patients
with heart failure, the aim would be to create new, tailor-made cardiac cells to
replace the damaged tissue. For patients with spinal injury, research would be
directed at the creation of new spinal tissue which could replace injured nerve
tissue allowing the patient to regain mobility in paralysed limbs. What part will
your company play in this? Find out today.

However, much of this global effort is currently being thwarted by issues that are
restraining progress in a way that has been unparalleled in the biotech and
pharmaceutical sector. How can your company get around these problems? What
opportunities are there for you? Find out today.

With these obvious frustrations, it is perhaps surprising that so much work on
embryonic stem cells, and to a lesser extent adult stem cells, continues but
governments and companies around the world are evolving new strategies to overcome
these limitations.

One successful product launch will change the face of modern medicine from a
situation where treatments and alleviation of suffering are the norm to one where
replacement parts are offered routinely.

This unique one-stop-shop of a report is the premier business analysis of the market
opportunities. Possible values to the market range from billions to perhaps
nothing. If the one product launch fails to deliver or, worse, has damaging
side-effects, then the market could just as easily collapse overnight. By reading
one report you can put your company to the forefront of stem cell business
knowledge.

Order your copy of this unique un-biased assessment, analysis, facts, figures,
tables and charts of how your market will develop. I urge you to order today.

Only a strict 20 copies of the report are issued. Please order your copy now so as
you do not miss out. Copies will be reserved on a strictly first-come-first-serve
basis. So please contact us now.

This report is a vital addition to gaining an understanding of this highly
profitable market sector and will give your company \'the edge\' of your competitors.
You can not afford to be without this report.

For more information, Please visit : http://www.bharatbook.com/detail.asp?id

Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium, Navi Mumbai - 400 614, India.
Ph. : +91-(022)-2757 8668 or +91-(022)-2757 9131
email : bharatbook@gmail.com